BWAY · BRAINSWAY LTD

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

16 Hartum St, Jerusalem, 9777516, Israel
Medical Devices
Healthcare

Market Cap

473.8M

52 Wk Range

$7.13 - $17.40

Previous Close

$11.47

Open

$11.36

Volume

104,053

Day Range

$11.36 - $12.13

Enterprise Value

497.9M

Cash

63.17M

Avg Qtr Burn

N/A

Insider Ownership

2.59%

Institutional Own.

29.64%

Qtr Updated

Jun 30th 2026